CTRI/2015/01/005374已完成未知
Evaluation of Efficacy and Safety of a Novel herbal composition LI80020F4 in improvement of Muscular Energy, Endurance and Muscle Strength in Resistance trained Healthy Male Subjects: A Randomized, Double-Blind, and Placebo-Controlled Study.
aila Nutraceuticals0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male subjects between 18-40 years of age
- •Ability to understand the risks/benefits of the protocol
- •Subjects familiar with weight training and have at least 6 months experience training, 4 times per week for at least 3 to 4hours. (Recreational athletes)
- •Agree to do physical activities as stated in the protocol in presence of physical trainer
- •Willingness to participate in an exercise program (4 days a week, during the course of the study)
- •Subjects should be available for duration of study period (7weeks)
- •Subject agrees not to start any new supplement which would affect body composition during the course of the study
- •Subjects agree to maintain the activity dairy
- •Willing to give written informed consent and willing to comply with trial protocol
排除标准
- •No contraindications to exercise as outlined by the American College of Sports Medicine (ACSM).
- •Use of nutritional supplements known to improve energy and muscle strength and/or muscle mass (e.g., Creatine, HMB, androstenedione, DHEA, etc.) within seven weeks prior to the start of the study.
- •All medications that can interfere with muscle mass such as corticosteroids (e.g. Prednisone), testosterone replacement or anabolic drugs.
- •Subjects who are under herbal supplements within seven (7) days prior to screening.
- •Subjects using any other therapies that would affect body composition other than those revealed during recruitment process.
- •Subjects having history of asthma.
- •Subjects having history of cardiovascular diseases.
- •Subjects having history of diabetes (Type I or Type II) except other than the subject having the pre-diabetes condition with the fasting blood glucose between 100 to 125 mg/dl or random blood glucose >= 140-199 mg/dl.
- •Subjects having thyroid disease.
- •Subjects having abnormal liver or kidney function tests (ALT or AST 2 times the upper limit of normal; elevated Creatinine, males 125 µmol/L,).
- •Subjects having abnormal findings on complete blood count
- •Subjects with HIV Positive.
- •Subjects having history of high alcohol intake (2 standard drinks per day).
- •Subjects having history of psychiatric disorder that may impair the ability of subjects to provide written informed consent.
- •Any other condition that, in the opinion of the investigator, would adversely affect the subjects ability to complete the study or its measures.
- •Subjects participated in any clinical study within thirty (30) days prior to screening.
研究者
相似试验
已完成
3 期
The effect of herbal supplement in type 2 diabetes treatment.Diabetes.E10-E14Diabetes mellitusIRCT201109207602N1Iran's National Elites Foundation (INEF)60
尚未招募
1 期
Studying the effectiveness of herbal blends for stress and anxiety along with improved mood status in healthy individuals.CTRI/2023/09/057859Sush Essentials Pvt. Ltd
进行中（未招募）
不适用
Evaluation of efficacy and safety of the herbal drug Myrrhinil-Intest vs. mesalazine in maintaining clinical remission of ulcerative colitis - a 12-month, multicenter, randomized, prospective, double-blind, double-dummy, active-controlled and parallel group phase IV-trial - MIRCulcerative colitis patients in clinical remissionMedDRA version: 9.1Level: LLTClassification code 10045365Term: Ulcerative colitisEUCTR2007-007928-18-DEREPHA GmbH
已完成
3 期
Evaluation of herbal mouthwah, Hasis on plaque induced gingivitisIRCT20180131038572N1Shahid Beheshti University of Medical Sciences25
尚未招募
2 期
Study of Herbal medicine in lowering blood pressure in comparison with standard medicineCTRI/2023/03/050643ational Innovation Foundation India